
|Articles|May 1, 2004
Men prefer newer PDE-5 inhibitors in German study
All three agents found highly efficacious at maximum- and half-dose regimens
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
PROSTOX ultra launches on US market following new data presented at ASTRO 2025
3
Published data show benefit of niraparib with AAP in HRR-deficient mCSPC
4
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
5